Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

GlaxoSmithKline Wins FDA Approval for Flu Vaccine

Big Pharma giant GlaxoSmithKline (NYSE: GSK  ) announced in a press statement earlier this week that the Food and Drug Administration has approved  its Fluarix Quadrivalent flu vaccine for adults and for children 3 or older. The company expects the vaccine to be available for the 2013-2014 flu season.

The vaccine will cover both  subtype A and B flu strains and is the first intramuscular  vaccine to cover four different flu strains. Typically, health-care providers order flu vaccines about a year before flu seasons occur.

Leonard Friedland,, vice president and head of GlaxoSmithKline's North America Vaccines and Clinical Development and Medical Affairs branch, said in the  release that "in six of the last 11 flu seasons, the predominant circulating influenza B strain was not the strain that public health authorities selected" and that "Fluarix Quadrivalent will help protect individuals against both B strains and, from a public-health standpoint, can help decrease the burden of disease."

GlaxoSmithKline faces a large, untapped market for flu vaccines. Typically, less  than 50% of individuals receive flu vaccines; the Centers for Disease Control target a rate of 80%.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2166970, ~/Articles/ArticleHandler.aspx, 3/27/2015 8:31:44 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...